Evobrutinib

CAS No. 1415823-73-2

Evobrutinib( M2951 | MSC2364447C | MSC 2364447 )

Catalog No. M11730 CAS No. 1415823-73-2

A potent, highly selective BTK inhibitor for the treatment of various autoimmune disorders.Rheumatoid ArthritisPhase 2 Clinical

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 85 In Stock
5MG 77 In Stock
10MG 123 In Stock
25MG 227 In Stock
50MG 323 In Stock
100MG 461 In Stock
200MG Get Quote In Stock
500MG 995 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Evobrutinib
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, highly selective BTK inhibitor for the treatment of various autoimmune disorders.Rheumatoid ArthritisPhase 2 Clinical
  • Description
    A potent, highly selective BTK inhibitor for the treatment of various autoimmune disorders.Rheumatoid Arthritis Phase 2 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    M2951 | MSC2364447C | MSC 2364447
  • Pathway
    Tyrosine Kinase
  • Target
    BTK
  • Recptor
    BTK
  • Research Area
    Inflammation/Immunology
  • Indication
    Rheumatoid Arthritis

Chemical Information

  • CAS Number
    1415823-73-2
  • Formula Weight
    429.51418
  • Molecular Formula
    C25H27N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 6.4 mg/mL (Need ultrasonic)
  • SMILES
    C=CC(N1CCC(CNC2=NC=NC(N)=C2C3=CC=C(OC4=CC=CC=C4)C=C3)CC1)=O
  • Chemical Name
    2-Propen-1-one, 1-[4-[[[6-amino-5-(4-phenoxyphenyl)-4-pyrimidinyl]amino]methyl]-1-piperidinyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Patent US20140162983 example 0174.
molnova catalog
related products
  • LFM-A13

    A highly specific inhibitor of BTK with Ki of 1.4 uM, IC50 of 17.2 uM.

  • BTK-IN-23

    BTK-IN-23 is a highly potent and selective Btk inhibitor with IC50 of 3 nM.

  • AVL-292

    AVL-292 (Spebrutinib, CC-292) is a highly selective, covalent Btk inhibitor with IC50 of <1 nM; also less potently inhibits Yes, c-Src, Brk, Lyn, and Fyn with IC50s of 723 nM, 1.729 uM, 2.43 uM, 4.4 uM, and 7.15 uM, rspectively.